Detailed Quote
Questions on this company?
Become a Member
Company Profile
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
- Biogen Inc. (BIIB)
- Gilead Sciences Inc. (GILD)
- Illumina Inc. (ILMN)
- AbbVie Inc. (ABBV)
- Abbott Laboratories (ABT)
- Eli Lilly and Company (LLY)
- Novo Nordisk A/S (NVO)
- iShares Biotechnology ETF (IBB)
- SPDR Biotech ETF (XBI)
- First Trust NYSE Arca Biotechnology ETF (FBT)
Q: Hi 5i, can you give me the names of 4 or 5 large cap pharmaceutical companies that are buyable now. Also I'm looking for 4 or 5 Biotech companies with one drug in the market making money and maybe something in the pipeline that looks like it has a good future? for example TGTX.
- Amgen Inc. (AMGN)
- Biogen Inc. (BIIB)
- Gilead Sciences Inc. (GILD)
- Regeneron Pharmaceuticals Inc. (REGN)
- Vertex Pharmaceuticals Incorporated (VRTX)
- AbbVie Inc. (ABBV)
- Abbott Laboratories (ABT)
- Bristol-Myers Squibb Company (BMY)
- Johnson & Johnson (JNJ)
- Eli Lilly and Company (LLY)
- Merck & Company Inc. (MRK)
- Pfizer Inc. (PFE)
Q: According to Portfolio Analytics, my current allocation to Health Care sector is too low. Here are the names of 12 major US pharmaceutical companies. How would you rank them? If possible, please provide a short comment on each of them: Pfizer, Johnson and Johnson, AbbVie, Amgen, Gilead Sciences, Eli Lilly, Merck, Vertex Pharmaceuticals, Regeneron Pharmaceuticals, Abbott, Biogen, Bristol Myers Squibbs. Thank you
- Biogen Inc. (BIIB)
- Intuitive Surgical Inc. (ISRG)
- AbbVie Inc. (ABBV)
- Eli Lilly and Company (LLY)
- Repligen Corporation (RGEN)
Q: Repligen is trading close to the 52-week low and would welcome your analysis of their recent operating performance and market potential looking forward. Post-pandemic and mindful of competitors in the same space does their stock have any opportunity to excel in the coming year, and if held as a position in a long-term growth portfolio, could you please rank the appeal of Repligen in descending order versus your go-to favorites in the same general space. Thanks kindly for your thoughts.
Insiders
Share Information
SEC Filings
News and Media